Compound Summary
nipecotic acid
Compound Information
nipecotic acid
Compound Name: | nipecotic acid |
Compound CID: | 4498 |
Synonyms: | nipecotic acid Piperidine-3-carboxylic acid 498-95-3 3-Piperidinecarboxylic acid h-dl-nip-oh More... |
Iupac Name: | piperidine-3-carboxylic acid |
InChI: | InChI=1S/C6H11NO2/c8-6(9)5-2-1-3-7-4-5/h5,7H,1-4H2,(H,8,9) |
InChIKey: | XJLSEXAGTJCILF-UHFFFAOYSA-N |
Canonical Smiles: | C1CC(CNC1)C(=O)O |
Isomeric Smiles: | C1CC(CNC1)C(=O)O |
Molecular Weight: | 129.16 |
Molecular Formula: | C6H11NO2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
nipecotic acid
Molecular Weight: | 129.16 |
Molecular Formula: | C6H11NO2 |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 3 |
Rotatable Bond Count: | 1 |
Heavy Atom Count: | 9 |
Complexity: | 114 |
Synonyms
nipecotic acid
| nipecotic acid | nipecotic acid |
|---|---|
nipecotic acid |
Piperidine-3-carboxylic acid |
498-95-3 |
3-Piperidinecarboxylic acid |
h-dl-nip-oh |
(+/-)-Nipecotic acid |
hexahydronicotinic acid |
60252-41-7 |
MFCD00005992 |
(+/-)-3-piperidine carboxylic acid |
CHEMBL277498 |
dl-piperidine-3-carboxylic acid |
CHEBI:116931 |
SR-01000075612 |
EINECS 207-873-9 |
Nipecotic |
dl-nipecotic acid |
h-nip-oh |
3-carboxypiperidine |
3-piperidinic acid |
(y)-Nipecotic acid |
(?)-Nipecotic acid |
(RS)-nipecotic acid |
h-dl-pic(3)-oh |
Nipecotic acid, 98% |
Spectrum_000353 |
ACMC-209ghf |
ACMC-209kiv |
Prestwick0_000950 |
Prestwick1_000950 |
Prestwick2_000950 |
Prestwick3_000950 |
Spectrum2_001184 |
Spectrum3_001712 |
Spectrum4_000169 |
Spectrum5_001412 |
(A+/-)-Nipecotic acid |
3-Piperidinecarboxylic acid (Nipecotic acid) |
(+/-)-beta-Homoproline |
nipecotic acid (+/-)- |
ACMC-209m9w |
piperidin-3-carboxylic acid |
3-aPiperidinecarboxylic acid |
3-piperidine carboxylic acid |
Lopac0_000041 |
SCHEMBL85677 |
BSPBio_000920 |
BSPBio_003324 |
KBioGR_000657 |
KBioSS_000833 |
MLS000069598 |
DivK1c_000148 |
SPECTRUM2300345 |
SPBio_001227 |
SPBio_003079 |
BPBio1_001012 |
GTPL4564 |
HMS500H10 |
KBio1_000148 |
KBio2_000833 |
KBio2_003401 |
KBio2_005969 |
KBio3_002544 |
DTXSID00870568 |
NINDS_000148 |
HMS1570N22 |
HMS2097N22 |
HMS2235L11 |
HMS3260I03 |
ACT02108 |
Tox21_500041 |
BBL018520 |
BDBM50003624 |
CCG-40009 |
PDSP1_000143 |
PDSP2_000142 |
SBB027313 |
STL193988 |
(+/-)-piperidine-3-carboxylic acid |
AKOS000120441 |
AKOS016347225 |
AC-2538 |
CS-W020556 |
LP00041 |
LS20781 |
MCULE-3189529983 |
PB29158 |
PB30681 |
PS-6088 |
SB10229 |
SB41071 |
SDCCGSBI-0050030.P003 |
VP80061 |
3-piperidinecarboxylic acid 498-95-3 |
IDI1_000148 |
MLS-0072915 |
( inverted question mark)-Nipecotic acid |
J Neurochem 25: 797 (1975) |
NCGC00014992-03 |
NCGC00014992-04 |
NCGC00014992-05 |
NCGC00014992-06 |
NCGC00014992-07 |
NCGC00014992-08 |
NCGC00014992-14 |
NCGC00024510-02 |
NCGC00024510-03 |
NCGC00024510-04 |
NCGC00024510-05 |
NCGC00260726-01 |
SMR000059031 |
SY001864 |
MLS-0072915.P019 |
AB0006610 |
DB-022674 |
AB00052417 |
AM20100216 |
C3380 |
EU-0100041 |
FT-0604479 |
FT-0630059 |
FT-0630291 |
FT-0693391 |
N0420 |
Piperidine-3-carboxylic acid(nipecotic acid) |
ST50998283 |
Q-200393 |
SR-01000075612-1 |
SR-01000075612-2 |
W-106000 |
Q11324593 |
( inverted question mark)-3-Piperidine carboxylic acid |
F0001-1300 |
Experimental Data
nipecotic acid
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | 1.000000000000000 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
nipecotic acid
Statistics Data
nipecotic acid
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 1.000000000000000 | 1 | 1 |
Statistics Data Visualization
nipecotic acid
